VitaMed is a specialty pharmaceutical company that has developed a patent pending technology and business methodology to market both over the counter OTC and prescription versions of nutritional supplements, drugs, medical foods and other medical products directly to consumers with the recommendation of their physician. VitaMed s business model creates unique value propositions for patients, physician/providers and insurance payors by eliminating much of the inefficiencies associated with the traditional sales, marketing and distribution models. VitaMed offers superior quality products for a lower overall cost to patients and payors while increasing efficiencies for physicians. VitaMed s technology allows it to collect and analyze data from various sources to improve patient compliance and education, facilitate product development and provide immediate feedback on effectiveness of therapies. The result is increased efficiency and communication between the patient, physician/provider and insurance payor, ultimately creating improved outcomes for all. This combination of efficient distribution and technology provides measurable customer benefits differentiates VitaMed from existing competitors in the market.
Quote | TherapeuticsMD Inc. (NASDAQ:TXMD)
Last: | $1.885 |
---|---|
Change Percent: | -0.53% |
Open: | $1.89 |
Close: | $1.885 |
High: | $1.9095 |
Low: | $1.8535 |
Volume: | 9,198 |
Last Trade Date Time: | 05/01/2024 03:00:00 am |
News | TherapeuticsMD Inc. (NASDAQ:TXMD)
2024-03-29 16:21:11 ET More on Therapeutics MD Financial information for Therapeutics MD Read the full article on Seeking Alpha For further details see: Therapeutics MD reports FY results
• Evaluation of strategic alternatives continues TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2023...
Message Board Posts | TherapeuticsMD Inc. (NASDAQ:TXMD)
Subject | By | Source | When |
---|---|---|---|
look to put money back in stocks around Feburary.. | jablome | investorshub | 12/29/2022 5:14:48 PM |
SaltyMutt: TY for reminding me of TXMD. I haven't thought about it in a while. | SaltyMutt | investorshangout | 12/05/2022 9:10:03 PM |
znewcar1: $TXMD HOD5.84 28% v2,15m $5.695 f9,467,104 | znewcar1 | investorshangout | 12/05/2022 6:41:07 PM |
November 30? | JCB5 | investorshub | 12/05/2022 2:07:06 PM |
should see bankruptcy or buyout soon on nov. | magacrew2020 | investorshub | 11/25/2022 5:45:40 PM |
News, Short Squeeze, Breakout and More Instantly...
• Evaluation of strategic alternatives continues TherapeuticsMD, Inc. (“TherapeuticsMD” or the “Company”) (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2023...
The Meaning Behind Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This...
What Defines a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's fut...